Two Randomized Controlled Pilot Trials of Social Forces to Improve Statin Adherence among Patients with Diabetes

ABSTRACTBackgroundMedication nonadherence is an important obstacle to cardiovascular disease management.ObjectiveTo improve adherence through real-time feedback based on theories of how social forces influence behavior.DesignTwo randomized controlled pilot trials called PROMOTE and SUPPORT. Participants stored statin medication in wireless-enabled pill bottles that transmitted adherence data to researchers.ParticipantsAdults with diabetes and a history of low statin adherence based on pharmacy refills (i.e., Medication Possession Ratio [MPR] <80 % in the pre-randomization screening period).InterventionIn PROMOTE, each participant was randomized to 1) weekly messages in which that participant’s statin adherence was compared to that of other participants (comparison), 2) weekly summaries of that participant’s statin adherence (summary), or 3) control. In SUPPORT, each participant identified another person (the Medication Adherence Partner [MAP]) to receive reports about that participant’s adherence, and was randomized to 1) daily reports to MAP, 2) weekly reports to MAP, 3) reports to MAP only if dose was missed, or 4) control.Main Outcomes MeasureAdherence measured by pill bottle.Key ResultsAmong 45,000 health plan members contacted by mail, <1 % joined the trial. Participants had low baseline MPRs (median = 60 %, IQR 41–72 %) but high pill-bottle adherence (90 % in PROMOTE, 92 % in SUPPORT) during the trial. In PROMOTE (n = 201) and SUPPORT (n = 200), no intervention demonstrated significantly better adherence vs. control. In a subgroup of PROMOTE participants with the lowest pre-study MPR, pill-bottle-measured adherence in the comparison arm (89 %) was higher than the control (86 %) and summary (76 %) arms, but differences were non-significant (p = 0.10).ConclusionsInterventions based on social forces did not improve medication adherence vs. control over a 3-month period. Given the low percentage of invited individuals who enrolled, the studies may have attracted participants who required little encouragement to improve adherence other than study participation.

[1]  R. Collins,et al.  Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90 056 participants in 14 randomised trials of statins , 2005, The Lancet.

[2]  David W. Bates,et al.  Clinical decision support systems could be modified to reduce 'alert fatigue' while still minimizing the risk of litigation. , 2011, Health affairs.

[3]  S. Powell,et al.  Psychometric characteristics of the Multidimensional Scale of Perceived Social Support. , 1990, Journal of personality assessment.

[4]  P. Farmer,et al.  Scaling-up HIV treatment programmes in resource-limited settings: the rural Haiti experience , 2004, AIDS.

[5]  L. Suter Educational Attainment in the United States: March 1977 and 1976. Current Population Reports, Population Characteristics, Series P-20, No. 314. , 1977 .

[6]  M. Dimatteo,et al.  Improving the measurement of self-reported medication nonadherence: response to authors. , 2011, Journal of clinical epidemiology.

[7]  Noah J. Goldstein,et al.  Social influence: compliance and conformity. , 2004, Annual review of psychology.

[8]  S. Grundy,et al.  National Cholesterol Education Program Third Report of the National Cholesterol Education Program ( NCEP ) Expert Panel on Detection , Evaluation , and Treatment of High Blood Cholesterol in Adults ( Adult Treatment Panel III ) Final Report , 2022 .

[9]  Judith A. Long,et al.  Peer Mentoring and Financial Incentives to Improve Glucose Control in African American Veterans , 2012, Annals of Internal Medicine.

[10]  B. Frey,et al.  Social Comparisons and Pro-social Behavior: Testing "Conditional Cooperation" in a Field Experiment , 2004 .

[11]  J. LeLorier,et al.  Intensive versus moderate lipid lowering with statins after acute coronary syndromes. , 2004, The New England journal of medicine.

[12]  Nilay D Shah,et al.  Long-term medication adherence after myocardial infarction: experience of a community. , 2009, The American journal of medicine.

[13]  T. Brennan,et al.  Asymmetric paternalism to improve health behaviors. , 2007, JAMA.

[14]  H. Allcott,et al.  Social Norms and Energy Conservation , 2011 .

[15]  P Michael Ho,et al.  Medication nonadherence is associated with a broad range of adverse outcomes in patients with coronary artery disease. , 2008, American heart journal.

[16]  G. Zimet,et al.  The Multidimensional Scale of Perceived Social Support , 1988 .

[17]  Sarah R. Crissey Educational Attainment in the United States: 2007. , 2009 .

[18]  H. Allcott,et al.  The Short-Run and Long-Run Effects of Behavioral Interventions: Experimental Evidence from Energy Conservation , 2012 .

[19]  H. Ward,et al.  Predictive Validity of a Medication Adherence Measure in an Outpatient Setting , 2008, Journal of clinical hypertension.

[20]  J. Steiner,et al.  A Systematic Review of the Literature , 2019, HIV/AIDS and Adolescents.

[21]  John Simes,et al.  Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90 056 participants in 14 randomised controlled trials of statins (vol 366, pg 1267, 2005) , 2008 .

[22]  J. Mukherjee,et al.  Antiretroviral Therapy in Resource-Poor Settings: Decreasing Barriers to Access and Promoting Adherence , 2006, Journal of acquired immune deficiency syndromes.

[23]  J. Slattery,et al.  Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S). 1994. , 1994, Atherosclerosis. Supplements.

[24]  J. Piette,et al.  The impact of tailored text messages on health beliefs and medication adherence in adults with diabetes: A randomized pilot study. , 2016, Research in social & administrative pharmacy : RSAP.

[25]  J. Mckenney,et al.  National Cholesterol Education Program Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) , 2002 .

[26]  J. Mukherjee,et al.  Improved retention associated with community-based accompaniment for antiretroviral therapy delivery in rural Rwanda. , 2013, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[27]  Scandinavian Simvastatin Survival Study Group Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S) , 1994, The Lancet.

[28]  Noah J. Goldstein,et al.  A Room with a Viewpoint: Using Social Norms to Motivate Environmental Conservation in Hotels , 2008 .

[29]  L. Green,et al.  Concurrent and Predictive Validity of a Self-reported Measure of Medication Adherence , 1986, Medical care.

[30]  Muhammad Mamdani,et al.  Adherence with statin therapy in elderly patients with and without acute coronary syndromes. , 2002, JAMA.

[31]  Judd B. Kessler,et al.  Can Social Information Affect What Job You Choose and Keep , 2017 .

[32]  N. Christakis,et al.  The Spread of Obesity in a Large Social Network Over 32 Years , 2007, The New England journal of medicine.